Skip to main content

Table 1 Patient clinical and histological characteristics

From: Downregulation of EphA5 by promoter methylation in human prostate cancer

  Prostate cancer (%) BPH (%)
Case, n 45 39
Age (mean ± SD, years) 69.5 ± 10.3 63.6 ± 9.1
TNM
T1 1 (2.2)  
T2 12 (26.7)
T3 14 (31.1)
T4 18 (40.0)
Gleason score
6-7 22 (48.9)  
8-10 23 (51.1)
PSA (ng/ml)
<4.0 2 (4.4) 4 (10.3)
4.0–10.0 7 (15.6) 21 (53.8)
>10.0 36 (80.0) 14 (35.9)
Prostate volume (ml)
<30 14 (31.1) 8 (20.5)
30–50 17 (37.8) 12 (30.8)
>50 14 (31.1) 19 (48.7)